	Association of alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer O'Connell CP, Berndt SI, Chudy-Onwugaje K, Kunzmann A, Huang WY, Barry KH, Loftfield E. PMID: 41582658 [PubMed - indexed for MEDLINE]
	Cathepsins E, O, and S: Novel Biomarkers and Therapeutic Targets in Breast Carcinoma. Curr Med Chem Ren D, Lv C, Dai J, Wu X, Meng X, Si Y, Ru J, Yao S, Wang O, Xiang J. PMID: 41582589 [PubMed - as supplied by publisher]
	Lactylation Plays a Novel Role in the Tumor Microenvironment and its Prognostic Implications for Breast Cancer. Recent Pat Anticancer Drug Discov Gao L, Yao H, Li Q. PMID: 41582583 [PubMed - as supplied by publisher]
	Discovery of Anoikis-correlated Biomarkers for Ovarian Cancer Through Integrated Transcriptome and Single-cell RNA Sequencing Analyses. Curr Top Med Chem Jiang X, An D, Fan S, Quan C, Zhu H, Zhang M. PMID: 41582369 [PubMed - as supplied by publisher]
	Novel Metabolic Reprogramming and Circadian Rhythm Related Molecular Subtyping and Prognostic Signature for Ovarian Cancer. Curr Med Chem Zeng Q, Wang Y, Wang Y, Yu Y, Lv Y, Wang M, Huang Z. PMID: 41582360 [PubMed - as supplied by publisher]
	Patient-reported outcomes after long-term period of niraparib maintenance in platinum-sensitive recurrent ovarian cancer: a prospective, multicenter cohort study. J Ovarian Res Du M, Peng P, Cao D, Cheng N, Yao L, Sun Y, Li J, Zhang H, Lou G, Tang J, Wang D, Wang Y, Zhang G, Xiang Y. PMID: 41582141 [PubMed - as supplied by publisher]
	Evaluation of the diagnostic value of DCE-MRI radiomics features and K-trans parameters in differentiating endometrial cancer from submucosal uterine fibroids. Magn Reson Imaging Su L, Wang K, Xiao S, Xu L, Hu J. PMID: 41581841 [PubMed - as supplied by publisher]
	KRAS Mutations Reshape the Immunosuppressive Tumor Microenvironment in Triple-Negative Breast Cancer: A Novel Perspective. Crit Rev Oncol Hematol Lv Y, Zhao Z, Di W, Liu L, Chen Y, Su W, Ji Y, Zhong J. PMID: 41581736 [PubMed - as supplied by publisher]
	Urinary arsenic levels and risk of breast cancer among women in the Canadian Health Measures Survey: a population-based prospective study. Environ Res Pullella K, Chang VC, Giannakeas V, Lubi, Harris SA, Hanley AJ, Narod SA, Kotsopoulos J. PMID: 41581689 [PubMed - as supplied by publisher]
	Patient-reported outcomes from the randomized ALICE trial evaluating the addition of atezolizumab to anthracycline-based chemotherapy in metastatic triple-negative breast cancer. Breast Svalheim KG, Andresen NK, Bjerre C, Gilje B, Jakobsen EH, Falk RS, Naume B, Kaasa S, Kyte JA. PMID: 41581361 [PubMed - as supplied by publisher]
	Practical Considerations for the Use of Antiemetics in Pregnant Patients With Breast Cancer. Clin Breast Cancer Duong A, Fritzsche D, Indorf AL. PMID: 41581332 [PubMed - as supplied by publisher]
	EHealth intervention for quality of life in long-term breast cancer survivors: Randomized controlled trial. J Natl Cancer Inst Pimentel-Parra GA, Soto-Ruiz N, Escalada-Hernández P, San Martín-Rodríguez L, García-Vivar C. PMID: 41581214 [PubMed - as supplied by publisher]
	Comparison of the effects of low- versus High-Supervision exercise on breast cancer survivorship outcomes. JNCI Cancer Spectr Bloomquist K, Spence RR, Vagenas D, Pyke C, Sandler CX, Rye S, Young L, Hayes SC. PMID: 41581141 [PubMed - as supplied by publisher]
	Human-AI interaction in a cancer-enriched double-reading breast screening cohort: diagnostic accuracy and second-reader behavior. Cancer Imaging Sossavi E, Tardy M, Hurstel F, Schwartz J, Wackenthaler A, Harter C, Uttner J, Mollion M, Bretz MF, Molière S. PMID: 41580866 [PubMed - as supplied by publisher]
	Healing dynamics and surgery in breast cancer: rethinking a timeless challenge in light of advancing therapies and technologies. J Transl Med Vinci S, Biciuffi R, Barbieri E, Annibalini G, Santi M, Lucini D, Bosisio D, Gaudenzi C, Gagliano N, Demicheli R, Biganzoli E, Tagliabue E, Bianchi F. PMID: 41580815 [PubMed - as supplied by publisher]
	Targeting microbiome-driven epigenetic modifications: a new frontier in breast cancer treatment. Clin Epigenetics Bai Y, Kong X, Wang J. PMID: 41580778 [PubMed - as supplied by publisher]
	Breast assessment using next generation handheld ultrasound device based on silicon chips: a pilot study in senology. Arch Gynecol Obstet Plöger R, Ludwig C, Nowozin G, Winkler K, Abramian A, Faridi A, Recker F. PMID: 41580544 [PubMed - indexed for MEDLINE]
	ASO Visual Abstract: The Value of Ultrasound in Patients with T1-T2 Breast Cancer with No Palpable Lymph Nodes Enrolled in the EORTC 10981-22023 AMAROS Trial. Ann Surg Oncol Beerthuizen AWJ, Snellen TIM, Bartels SA, Kuijer A, Poncet C, Drukker CA, Rutgers EJT, Peeters MJTFDV, van Duijnhoven FH. PMID: 41580533 [PubMed - as supplied by publisher]
	Perioperative micro-arterial function and extravasation in cytoreductive ovarian cancer surgery: an observational study. Intensive Care Med Exp Feldheiser A, Dathe JJ, Heinig S, Peitzner K, Kaufner L, Hunsicker O, von Haefen C, Sehouli J, Spies C. PMID: 41580514 [PubMed]
	Predicting the Efficacy of Breast Cancer Neoadjuvant Chemotherapy Using Ultrasonography and Machine Learning. Ultrasound Med Biol Jia M, Li H, Xiao W, Xue J, Wang Z, He X, Wang X, Men D. PMID: 41580311 [PubMed - as supplied by publisher]

Articles 1 - 20 / 323334

Page 1 of 16167



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy